Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management. Can Diabetes Endocrinol Today [Internet]. 16 déc. 2025 [cité 28 mars 2026];3(s01):2–8. Disponible à: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/3-s01-Jain